FEDERATED HERMES, INC. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,889,697
-11.1%
1,351,900
+27.1%
0.07%
-5.1%
Q2 2023$31,383,885
+28.1%
1,063,5000.0%0.08%
+25.8%
Q1 2023$24,503,040
+13.7%
1,063,500
+37.2%
0.06%
+3.3%
Q4 2022$21,552,750
+7.0%
775,000
+18.0%
0.06%
+1.7%
Q3 2022$20,151,000
+2.4%
656,593
-1.8%
0.06%
+9.3%
Q2 2022$19,687,000
-32.4%
668,929
-26.1%
0.05%
-18.2%
Q1 2022$29,122,000
-11.2%
905,245
+23.1%
0.07%
+8.2%
Q4 2021$32,800,000
+91.7%
735,432
+116.8%
0.06%
+84.8%
Q3 2021$17,110,000
+57.3%
339,160
+144.6%
0.03%
+65.0%
Q2 2021$10,874,000
+46.5%
138,632
+6.7%
0.02%
+42.9%
Q1 2021$7,421,000
-62.2%
129,960
-44.5%
0.01%
-65.0%
Q4 2020$19,617,000
+327.1%
234,200
+82.7%
0.04%
+263.6%
Q3 2020$4,593,000
-31.5%
128,195
-53.8%
0.01%
-35.3%
Q2 2020$6,709,000
+211.5%
277,463
+167.4%
0.02%
+240.0%
Q2 2019$2,154,000
-9.9%
103,755
+0.8%
0.01%
-16.7%
Q1 2019$2,390,000102,9220.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders